Moderna
$190.01Change from previous close: +0.57%Absolute change: +$1.07
At a glance
- Revenue growth
- −39.93%
- 2025 vs 2024
- Net margin
- -145.2%
- 2024: -110.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1,873 | -3,004 | -3,118 | 4,981 | 13,620 | 2,027 | -459 | -331 | -331 | 66.7 |
| Depreciation and amortization | 215 | 189 | 621 | 348 | 232 | 93.0 | 31.0 | 24.9 | 20.5 | 15.1 |
| Capital expenditure | -192 | -1,051 | -707 | -400 | -284 | -68.0 | -32.0 | -106 | -58.4 | -33.1 |
| Investing cash flow | 1,946 | 1,949 | 4,206 | -5,176 | -8,523 | -1,672 | -15.0 | -373 | 417 | -649 |
| Financing cash flow | 593 | 56.0 | -1,377 | -3,448 | -873 | 2,033 | 52.0 | 1,227 | 0.2 | 473 |
| Dividends paid | — | — | — | — | — | — | — | — | -1.5 | -0.6 |
| Share repurchases | -2.0 | 0.0 | -1,153 | -3,329 | -857 | — | — | — | — | — |
| Debt issued | 600 | 0.0 | 0.0 | — | — | — | 1.0 | 11.6 | 2.7 | — |
| Debt repaid | -18.0 | -10.0 | -270 | -184 | -140 | -6.0 | — | -2.2 | -1.3 | — |
| Effect of exchange rates | 2.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Net change in cash | 668 | -999 | -289 | -3,643 | 4,224 | 2,388 | -422 | 523 | 86.0 | -109 |
| Free cash flow | -2,065 | -4,055 | -3,825 | 4,581 | 13,336 | — | — | — | — | — |
| Levered free cash flow | -1,327 | -3,088 | -2,359 | 3,668 | 9,293 | 2,190 | -329 | -252 | -136 | — |